The vision for TARIPH as a ‘national academic platform’ for respiratory academia in Singapore was first published as an invited ‘Letter from Singapore’ in the January 2018 issue of Respirology, the official journal of the Asian-Pacific Society of Respirology. On 19 March 2018, this vision became reality as TARIPH was officially launched and featured in a follow up article entitled “International research collaboration: The way forward”.

Having gained traction as a leading local and international centre for academic respiratory research, TARIPH has since evolved into a Centre for respiratory research to maximise our capabilities, outreach and resources to pursue new opportunities. 

TARIPH encompasses research interest groups that focus on the healthy and diseased lung. It aligns basic, translational and clinical questions from the primary to tertiary care settings, including health-services orientated research to seamlessly integrate exchanges between our various stakeholders. 

TARIPH harnesses existing clinical strengths, synergises national efforts to improve lung health and provides a collective manifesto to: 

1. ​Improve respiratory health through research by better understanding its unique features, health, economic and social consequences in Singapore; 
2. Educate and inform society about  the importance of respiratory health and disease prevention; and 
3. Support collaborative grant applications at the individual and/or programme level.